We also confirm inhibition of cell-cycle-related pathways and activation of proinflammatory pathways in MDD with CRP < 1 mg/L, but only in current MDD (not in responders), further corroborating the hypothesis that these transcriptional mechanisms might prevent the development of clinical inflammation in people with current depression. This evidence concerns the gene CRP and depressive symptom measurement.